Part 10 of our Bridging the Gap Series (Summary of the webinar session held in September 2024) Access to life-saving cell and gene therapies is one of the most critical challenges facing healthcare today. While these therapies offer remarkable hope for patients battling life-threatening conditions like cancer and rare genetic diseases, the reality is that only a […]
View Blog
Part 9 of our Bridging the Gap Series (Summary of the webinar session held in August 2024) In the evolving landscape of cell and gene therapy, the manufacturing process is a crucial factor in ensuring that innovative treatments, such as CAR T-cell therapies, reach patients effectively. Autologous cell therapies, which involve modifying a patient’s own cells, present […]
View Blog
Imagine a scenario where a prominent life sciences company safeguards 573,000 biological samples collected two decades ago during a groundbreaking study. Today, these samples rest in a tucked-away basement of a modest laboratory, nestled among numerous cryogenic freezers within a section of the building inaccessible to anyone involved in the original research. The samples intermingle […]
View Blog
Part 8 of our Bridging the Gap Series (Summary of the webinar session held in July 2024) Imagine harnessing your body’s own immune cells to fight and destroy cancer—a reality that Tumor-Infiltrating Lymphocytes (TIL) therapy is making possible. TIL therapy was the key topic of our July “Bridging the Gap” webinar with guest speaker Raj Puri, M.D., […]
View Blog
Part 7 of our Bridging the Gap Series (Summary of the webinar session held in June 2024) What if you could transform the life of a child with leukemia by simply modifying their own cells? This is the promise of CAR T-cell therapy, a groundbreaking treatment that has already revolutionized cancer care. Yet, as Siddhartha Mukherjee, M.D., […]
View Blog
Part 6 of our Bridging the Gap Series (Summary of the webinar session held in May 2024) Welcome to another installment of the Bridging the Gap webinar series, your go-to place for the latest in cell and gene therapy. Presented by Azenta Life Sciences and the Emily Whitehead Foundation, this series is all about connecting the dots between […]
View Blog
The field of cell and gene therapy (CGT) is experiencing an exciting transformation, marked by the recent FDA approval for the first CRISPR-based sickle cell treatment. As the CGT landscape rapidly expands, it’s important for stakeholders to address the challenges of scalability head-on. Cryopreservation emerges as a critical yet understated element in the scalability equation, essential for […]
View Blog
Part 5 of our Bridging the Gap Series (Summary of the webinar session held in April 2024) The April 5, 2024, the Bridging the Gap webinar brought together experts and patients in a dynamic discussion that highlighted the groundbreaking advancements and persistent challenges in the field of cell and gene therapy (CGT), particularly in cancer immunotherapy. Guest […]
View Blog
Part 4 of our Bridging the Gap Series (Summary of the webinar session held in March 2024) In the rapidly evolving landscape of cell and gene therapy, stakeholders from across the industry are coming together to envision the future of these groundbreaking treatments. Recently, a panel of experts engaged in a thought-provoking discussion as part of the Bridging […]
View Blog
Part 3 of our Bridging the Gap Series (Summary of the webinar session held in February 2024) Gene therapy has emerged as a promising frontier in modern medicine, offering revolutionary treatments for a range of diseases previously considered incurable. In a recent webinar as part of the Bridging the Gap series, guest speaker Dr. Bruce Levine, a cancer […]
View Blog